Altimmune Ownership

Altimmune holds a total of 71.12 Million outstanding shares. Over half of Altimmune's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Altimmune in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Altimmune, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Dividends Paid is likely to drop to about 148 M in 2024. Dividend Paid And Capex Coverage Ratio is likely to gain to -1,532 in 2024. Common Stock Shares Outstanding is likely to gain to about 55.9 M in 2024, despite the fact that Net Loss is likely to grow to (72.4 M). Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.